A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCC

NCT02721563 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

77

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Neoplasms

Interventions

DRUG: Sodium Glycididazole
DRUG: Placebo

Sponsor

Shandong Cancer Hospital and Institute